Eradication Begins With Molecular Diagnostics Becoming The Standard of Care in Resource Limited Settings
Bienvenue
Welcome
Eradicus is a molecular diagnostics R&D and manufacturing company that exists for the sole mission of making molecular diagnostics highly accessible across resource limited settings.
Eradicus
At A Glance
We were founded in 2019 in Gémenos, France.
​
We grew exponentially during the COVID-19 pandemic principally due to our unique approach of enhancing accessibility of molecular diagnostic testing across developing and developed economies.
​
Since 2020, we have focused solely on R&D of cutting-edge technology platforms and IVD designs for a large variety of infectious pathogens.
>5 million
IVD Medical Devices Manufactured
>70
Infectious Pathogens Covered by Our R&D Pipeline
ISO
13485
Manufacturing
Accreditation
>100
In-Vitro Diagnostic Devices Under
Development
Gémenos, France
Research Headquarters
Gurugram, India
Development and Manufacturing
Headquarters
Technological Expertise & Differentiation
At Eradicus our R&D strategy is based on developing cutting-edge technologies that cut-short processing times and build in-house capabilities to support price disruptions on gold-standard chemistries.
​
Loop Mediated Isothermal Amplification 'LAMP' is a molecular biology based chemistry that cleverly uses a specific oligonucleotide assay design methodology to detect DNA/RNA nucleic acids in under 30 minutes (in comparison RT-PCR typically takes >90 minutes).
​
We are one of only a handful of companies across the world that has the technical know-how to develop in-vitro diagnostic assays on the basis of LAMP chemistry.
High-Throughput R&D Pipeline
With over 70 infectious pathogens and over 100 IVD designs.
Eradicus is now maturing its designs into regulatory approved IVD medical devices.